Albrecht Meichle

Company: Vaximm GmbH

Seminars:

Optimizing Release Testing for Faster Turnaround Time to Patients In Critical Need 2:00 pm

Novel and innovative methods to ensure release of safe products in a faster manner Implementation of quality controls assays at each scale up step Developing more flexible, risk based approach to release testing to allow for conditional releaseRead more

day: Day Two Track B AM

Panel Discussion: Examining the Impact of the Pandemic on Global Supply Chain to Gain Insight Into Next Strategy Steps 2:30 pm

Discussing strategy for producing cancer vaccines on an industrial scale under GMP conditions Exploring how companies have handled the low availability of raw materials (DNA vectors/ viral vectors) due to priority of Covid-19 for manufacturers Assessing the best strategy to deal with the logistical manufacturing issues that have arisen due to the pandemic Providing insight…Read more

day: Day Two Track B AM